(Q39200177)

9 September 2017

title

Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells (English)

1 reference

9 September 2017

1 reference

Yan Lan

1

1 reference

9 September 2017

Xiufeng Liu

2

1 reference

9 September 2017

Rong Zhang

3

1 reference

9 September 2017

Kai Wang

4

1 reference

9 September 2017

Yao Wang

5

1 reference

9 September 2017

Zi-Chun Hua

6

1 reference

9 September 2017

publication date

2 February 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

26

1 reference

9 September 2017

issue

2

1 reference

9 September 2017

page(s)

241-254

1 reference

Signalling pathways of the TNF superfamily: a double-edged sword

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

The effect of lithium chloride on tumour appearance and survival of melanoma-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Advances in noninvasive pulmonary gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Use of lithium in the treatment of bipolar disorder in late-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Transforming growth factor beta-1 enhances cytotoxic effect of doxorubicin in human lung adenocarcinoma cells of A549 line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Effects of lithium on thrombopoiesis in patients with low platelet cell counts following chemotherapy or radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Effects of lithium carbonate on hematopoietic cells in patients with persistent neutropenia following chemotherapy or radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Desferrioxamine (DFX) induces apoptosis through the p38-caspase8-Bid-Bax pathway in PHA-stimulated human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Lithium modulates cancer cell growth, apoptosis, gene expression and cytokine production in HL-60 promyelocytic leukaemia cells and their drug-resistant sub-clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

JNK inhibitor SP600125 promotes the formation of polymerized tubulin, leading to G2/M phase arrest, endoreduplication, and delayed apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

GSK-3β-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

The anti-proliferative effect of lithium chloride on melanoma cells and its reversion by myo-inositol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Lithium detaches hexokinase from mitochondria and inhibits proliferation of B16 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Molecular targets of lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

The farnesyltransferase inhibitor R115777 up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Neuroprotective and neurotrophic effects of long term lithium treatment in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Lithium sensitizes tumor cells in an NF-kappa B-independent way to caspase activation and apoptosis induced by tumor necrosis factor (TNF). Evidence for a role of the TNF receptor-associated death domain protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Lithium can relieve translational repression of TOP mRNAs elicited by various blocks along the cell cycle in a glycogen synthase kinase-3- and S6-kinase-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Involvement of the role of Chk1 in lithium-induced G2/M phase cell cycle arrest in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10534-012-9607-X

10.1007/S10534-012-9607-X

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference